Navigation Links
Boehringer Ingelheim's Swiss Branch Improves Sales Reporting and Efficiency with MicroStrategy Software
Date:8/26/2009

MCLEAN, Va., Aug. 26 /PRNewswire-FirstCall/ -- MicroStrategy((R)) Incorporated (Nasdaq: MSTR), a leading worldwide provider of business intelligence (BI) software, today announced that Boehringer Ingelheim (Schweiz) GmbH (named here as Boehringer Switzerland) has selected MicroStrategy to improve its sales reporting and efficiency. Boehringer Switzerland is the Swiss branch of the international pharmaceuticals company Boehringer Ingelheim.

Boehringer Switzerland selected MicroStrategy for reporting and analysis of sales productivity data. With MicroStrategy, sales data can now be supplied more rapidly to field sales and management, which helps the company to streamline operations. With MicroStrategy's flexible, user-friendly reports, individual users can create their own reports and work more efficiently. In addition, the reports give Boehringer Switzerland management greater insights into market data to help them plan sales activity and analyze the productivity of regional sales groups.

As part of its extensive selection process, the Boehringer Switzerland management team defined 10 Key Performance Indicators and asked selected BI providers to create several reports with this information. "MicroStrategy made an excellent impression during our evaluation process. In addition, our team in Australia has already deployed MicroStrategy for reporting and has had positive results," said Mr. Gregor Brunner, Department Manager IT of Boehringer Switzerland.

"MicroStrategy provides greater reporting capabilities than other BI suppliers and is very user-friendly," explained Alexander Herter, Business Analyst at Boehringer Switzerland and Project Manager for the evaluation of the new BI solution. "Data can be supplied rapidly and more clearly with MicroStrategy, and the reports serve as a basis for operational and strategic decisions."

"We are pleased to have the Swiss branch of Boehringer Ingelheim, one of the world's leading pharmaceutical companies, as our new customer," said Sanju Bansal, MicroStrategy's COO.

About Boehringer Switzerland

The Boehringer headquarters is in Ingelheim, Germany and the enterprise Boehringer Ingelheim is one of the world's 20 leading pharmaceutical companies. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.

About MicroStrategy

Founded in 1989, MicroStrategy is a global leader in business intelligence (BI) technology. MicroStrategy provides integrated reporting, analysis, and monitoring software that helps leading organizations worldwide make better business decisions every day. Companies choose MicroStrategy for its advanced technical capabilities, sophisticated analytics, and superior data and user scalability. More information about MicroStrategy (Nasdaq: MSTR) is available at www.microstrategy.com.

MicroStrategy and MicroStrategy Business Intelligence Platform are either trademarks or registered trademarks of MicroStrategy Incorporated in the United States and certain other countries. Other product and company names mentioned herein may be the trademarks of their respective owners.

    Contact:
    Wende Cover
    MicroStrategy Incorporated
    703-770-1646
    wcover@microstrategy.com


'/>"/>
SOURCE MicroStrategy Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Boehringer Ingelheim to Commence Phase III Study Investigating the Role of BIBW 2992 as First-Line Treatment for Non-Small Cell Lung Cancer (NSCLC) Patients with EGFR Mutations
2. AmeriCares and Boehringer Ingelheim Open New, Expanded Free Clinic to Help Families Hit Hardest by Economic Hardship
3. Boehringer Ingelheim Recognized For Diversity And Inclusion Efforts
4. Boehringer Ingelheim Plans to Launch U.S. Registry to Assess the State of Anticoagulation Therapy for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation
5. Final Patient Completes Treatment In Boehringer Ingelheims RE-LY(R) Study, The Largest Atrial Fibrillation Outcomes Trial To Date
6. Dalton Pharma Services and Boehringer Ingelheim (Canada) Ltd. Announce the Renewal of their Chemistry Services Agreement
7. Boehringer Ingelheim Appoints Albert Ros as Executive Vice President of Sales and Marketing for Prescription Medicines
8. Do the Swiss Have the Answer to Americas Health Care Dilemma?
9. EMH Swiss Medical Publisher Ltd. Selects Editorial Manager for Online Peer Review
10. Swissray Awarded US Government Contract
11. Swiss Res Employer Stop Loss Product Offers US Companies Cost Savings for Self-Funded Health Insurance Plans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June ... , brings up a new, often overlooked aspect of head lice: the parasite’s ability to ... is not a common occurrence, but a necessary one in the event that lice have ...
(Date:6/25/2016)... ... 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the Maryland ... iHire in recognition of their exemplary accomplishments in worksite health promotion. , The Wellness ... & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one of ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her son ... lash out at his family verbally and physically. , “When something upset him, he couldn’t ... would use it. He would throw rocks at my other children and say he was ...
(Date:6/24/2016)... ... ... of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum Wage’ ... 2020 and then adjusting it yearly to increase at the same rate as the median ... floor does not erode again, and make future increases more predictable. , The company is ...
(Date:6/24/2016)... Maryland (PRWEB) , ... June 24, 2016 , ... ... Angels is actively feeding the Frederick area economy by obtaining investment capital for ... over the past 2½ years that have already resulted in more than a ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... BEIJING , June 24, 2016 Dehaier ... or the "Company"), which develops, markets and sells medical ... China , signed a strategic cooperation agreement with ... as "Hongyuan Supply Chain") on June 20, 2016, to ... Under the strategic cooperation agreement, Dehaier will leverage Hongyuan ...
(Date:6/24/2016)... , Belgium , June 24, ... VNRX), today announced the appointment of Dr. ... Directors as a Non-Executive Director, effective June 23, ... Audit, Compensation and Nominations and Governance Committees.  As ... Futcher will provide independent expertise and strategic counsel ...
(Date:6/23/2016)... 2016 Research and Markets has ... by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), ... Parenteral) - Global Forecast to 2021" report to ... The global pharmaceutical excipients market is projected to reach ... 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology: